Intraoral somatosensory sensitivity in patients with atypical odontalgia (AO) has not been investigated systematically according to the most recent guidelines. The aims of this study were to examine intraoral somatosensory disturbances in AO patients using healthy subjects as reference, and to evaluate the percent agreement between intraoral quantitative sensory testing (QST) and qualitative sensory testing (QualST). Forty-seven AO patients and 69 healthy control subjects were included at Universities of Washington, Malmö, and Aarhus. In AO patients, intraoral somatosensory testing was performed on the painful site, the corresponding contralateral site, and at thenar. In healthy subjects, intraoral somatosensory testing was performed bilaterally on the upper premolar gingiva and at thenar. Thirteen QST and 3 QualST parameters were evaluated at each site, z-scores were computed for AO patients based on the healthy reference material, and LossGain scores were created. Compared with control subjects, 87.3% of AO patients had QST abnormalities. The most frequent somatosensory abnormalities in AO patients were somatosensory gain with regard to painful mechanical and cold stimuli and somatosensory loss with regard to cold detection and mechanical detection. The most frequent LossGain code was L0G2 (no somatosensory loss with gain of mechanical somatosensory function) (31.9% of AO patients). Percent agreement between corresponding QST and QualST measures of thermal and mechanical sensitivity ranged between 55.6% and 70.4% in AO patients and between 71.1% and 92.1% in control subjects. In conclusion, intraoral somatosensory abnormalities were commonly detected in AO patients, and agreement between quantitative and qualitative sensory testing was good to excellent. Ó
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Introduction
Atypical odontalgia (AO) is an enigmatic chronic orofacial pain condition with no objective signs of pathology [2,4,13,14,18,25, 26]. AO has also been termed phantom tooth pain [17] , persistent dentoalveolar pain (PDAP) [19] , peripheral painful traumatic trigeminal neuropathy [8] , and persistent idiopathic orofacial pain (PIOP) [1] . It is generally agreed that AO is not a suitable term because it reveals nothing about the pain mechanisms. The most prevailing hypothesis about AO pain mechanisms is that it is a neuropathic pain condition [2,13,18,27]. However, it is difficult to perform confirmatory tests of nerve pathology or damage intraorally. According to recent guidelines, both demonstration of somatosensory abnormalities and other confirmatory tests, such as electrophysiological tests or special neuroimaging techniques, are required for a definite diagnosis of neuropathic pain [8, 24] . The level of certainty of the pain being neuropathic is only possible or probable without such confirmatory tests.
Somatosensory sensitivity can be measured with quantitative sensory testing (QST) [10] [11] [12] 16, [20] [21] [22] [23] [24] . Fortunately, recent years have provided much progress with regard to standardization of QST, starting with the formation of the German Research Network on Neuropathic Pain (DFNS) and the publication of a standardized QST protocol for examination and data analysis [16, 21] . The German Network introduced the somatosensory profiles and LossGain
